Ahmed Nadim (CIK 0001731193)

Latest company ownership

Shares held
430,621
Last filed at
Feb 27, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
2,908
Last filed at
Nov 27, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 25, 2025 Feb 27, 2025 Cullinan Therapeutics, Inc. CEO Sell 22.5 -12,529 -2.83% ✗ $106.9K
Dec 24, 2024 Dec 27, 2024 Cullinan Therapeutics, Inc. CEO Sell 22.5 -8,400 -3.09% ✗ $99.7K
Dec 26, 2023 Dec 27, 2023 Cullinan Therapeutics, Inc. CEO Sell 26.3 -4,272 -3.69% ✗ $39.5K
Jun 28, 2023 Jun 29, 2023 Cullinan Therapeutics, Inc. CEO Sell 37.5 -759 -0.65% ✗ $8.7K
May 23, 2023 May 24, 2023 Cullinan Therapeutics, Inc. CEO Sell 37.5 -707 -0.60% ✗ $6.5K
Apr 25, 2023 Apr 26, 2023 Cullinan Therapeutics, Inc. CEO Sell 37.5 -716 -0.61% ✗ $7.6K
Mar 23, 2023 Mar 27, 2023 Cullinan Therapeutics, Inc. CEO Sell 37.5 -706 -0.59% ✗ $7.4K
Jun 6, 2022 Jun 7, 2022 Cullinan Therapeutics, Inc. CEO Buy 95.0 +8,090 100.00% ✗ $100.3K
Dec 31, 2020 Jan 5, 2021 BRISTOL MYERS SQUIBB CO President Sell 20.0 -7,660 -15.79% ✗ $475.1K
Dec 2, 2020 Dec 3, 2020 BRISTOL MYERS SQUIBB CO President Sell 22.5 -3,380 -9.15% ✗ $210.2K
Oct 30, 2020 Nov 3, 2020 BRISTOL MYERS SQUIBB CO President Sell 22.5 -2,291 -7.02% ✗ $133.9K
May 1, 2020 May 5, 2020 BRISTOL MYERS SQUIBB CO President Sell 22.5 -1,433 -4.87% ✗ $86.4K
Mar 1, 2020 Mar 3, 2020 BRISTOL MYERS SQUIBB CO President Sell 20.0 -8,473 -24.21% ✗ $500.4K
Feb 4, 2020 Feb 6, 2020 BRISTOL MYERS SQUIBB CO President Sell 22.5 -1,071 -5.68% ✗ $68.9K